CIM Investment Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$602K Buy
1,137
+77
+7% +$35.5K 0.14% 113
2026
Q1
$509K Hold
1,060
– – 0.14% 131
2025
Q4
$595K Hold
1,060
– – 0.16% 107
2025
Q3
$545K Sell
1,060
-1,142
-52% -$499K 0.15% 114
2025
Q2
$712K Buy
2,202
+1,105
+101% +$332K 0.14% 142
2025
Q1
$334K Sell
1,097
-26
-2% -$8.75K 0.08% 162
2024
Q4
$373K Hold
1,123
– – 0.11% 156
2024
Q3
$375K Hold
1,123
– – 0.11% 154
2024
Q2
$463K Sell
1,123
-266
-19% -$105K 0.14% 131
2024
Q1
$561K Hold
1,389
– – 0.17% 119
2023
Q4
$426K Hold
1,389
– – 0.14% 148
2023
Q3
$336K Hold
1,389
– – 0.12% 166
2023
Q2
$334K Buy
+1,389
New +$289K 0.11% 173
2022
Q4
– Sell
-1,393
Closed -$219K – 255
2022
Q3
$219K Hold
1,393
– – 0.1% 190
2022
Q2
$208K Hold
1,393
– – 0.09% 202
2022
Q1
$228K Sell
1,393
-162
-10% -$26.7K 0.08% 210
2021
Q4
$338K Hold
1,555
– – 0.1% 194
2021
Q3
$294K Hold
1,555
– – 0.09% 205
2021
Q2
$275K Hold
1,555
– – 0.09% 226
2021
Q1
$255K Buy
+1,555
New +$238K 0.08% 241

Other funds holding MEDP

CIM Investment Management's MEDP Position: Q2 2026 in Review

CIM Investment Management increased its Medpace (MEDP) stake by 7.3% in Q2 2026, buying an estimated $35.5K and bringing the position to 1,137 shares worth $602K. The position accounts for 0.14% of the portfolio, ranked #113.

CIM Investment Management first reported a position in MEDP in Q1 2021 and has held it in 20 quarters since. The position peaked at $712K in Q2 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • CIM Investment Management held 1,137 shares of Medpace worth $602K as of Q2 2026.
  • CIM Investment Management bought 77 Medpace shares in Q2 2026, an estimated $35.5K.
  • Medpace made up 0.14% of CIM Investment Management's portfolio in Q2 2026, its #113 holding.
  • CIM Investment Management first reported a position in Medpace in Q1 2021 and has held it in 20 quarters since.
  • CIM Investment Management's Medpace position peaked at $712K in Q2 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on CIM Investment Management's 13F filing for Q2 2026, filed 29 Sep 2026.